netFormulary NHS
Shropshire and Telford Local Health Economy
Shropshire, Telford and Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Shropshire Community Health NHS Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
08.03.04.01  Expand sub section  Breast cancer
Anastrozole
(Breast cancer,
1mg)
View adult BNF View SPC online
Formulary
Amber
NHS England
 
   
Exemestane
(25mg)
View adult BNF View SPC online
Formulary
Amber
 
   
Fulvestrant (Faslodex)
(250mg)
View adult BNF View SPC online
Formulary
Red
 
Link  NICE TA239: Fulvestrant for the treatment of locally advanced or metastatic breast cancer
   
Goserelin (Zoladex)
(Breast cancer,
3.6mg,)
View adult BNF View SPC online View childrens BNF
Formulary
Red
High Cost Medicine
 
   
Letrozole
(25mg)
View adult BNF View SPC online
Formulary
Amber

NHSEHomecare for fertility

 
   
Palbociclib (Ibrance)
View adult BNF View SPC online
Formulary
Red
High Cost Medicine
NHS England
BlueTeq

This drug is NHSE funded for the indications outlined within the Ex-Tariff list

 
Link  NICE TA495:-Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
Link  NICE TA619: Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer
   
Tamoxifen
(Breast cancer/ mastocytosis,
10mg/ml
20mg)
View adult BNF View SPC online
Formulary
Amber
 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Suitable first-line drugs for implementation in Primary Care  

Amber

These medicines are considered suitable for prescribing in Primary Care following specialist (consultant or GPwSI) initiation or recommendation. Some of these medicines may require on-going communication between the Secondary Care specialist and the Primary Care prescriber using Prescribing Information (PI) or through the use of an Effective Shared Care Agreement (ESCA) and this will be indicated in the text.  

Red

Drugs which require special consideration. These are drugs for use in Secondary Care ONLY, Consultant Prescribing ONLY or by Tertiary Centres ONLY where indicated in the text. They should not be prescribed in Primary Care.  

Black

Medicines classified in the BNF as 'not NHS' or are considered by the Area Prescribing Committee to be of low clinical value should not be prescribed  

netFormulary